Delivery Order SPE2DB20D1100-SPE2DB25FZ10M

Award Date 11/18/24
Potential Completion Date 12/10/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price of $14,484.30 and a completion date of September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,480.00 firm-fixed-price contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S medical supplies. It has an ultimate completion date of May 5, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,484.30, is for the delivery of BRUKINSA 80 MG CAPSULE 120S, with a completion date of November 25, 2024. The contract is a firm fixed-price agreement, and there is no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a firm-fixed price and a ceiling value of $12,740.00. The contract has an ultimate completion date of June 17, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price of $12,740.00 and a completion date of July 15, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRUKINSA 80 MG CAPSULE 120S. The $6,370.00 firm fixed price contract has a period of performance through June 10, 2025. The award is not set-aside and represents an order under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,370.00, is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,480.00, is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract is classified as a firm fixed-price delivery order and is not set aside for any specific business type. It has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $14,484.30 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 120 capsules of the drug BRUKINSA 80 MG. The contract has an ultimate completion date of October 2, 2024. This award is part of a larger indefinite delivery contract with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which allows the agency to efficiently procure a range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $19,110.00, is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of July 8, 2025. This contract is not set-aside and represents open competition. AmerisourceBergen Drug Corp holds a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FZ10M
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract, valued at $11,103.42, has a firm fixed price and an ultimate completion date of December 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. There is no set-aside designation mentioned for this particular award.

Generated 2/17/25, 9:55 PM